Lack of KRAS and BRAF Mutation in Renal Cell Carcinoma

被引：29
|
作者：
Gattenloehner, S. [1 ]
Etschmann, B. [1 ]
Riedmiller, H. [2 ]
Mueller-Hermelink, H.-K. [1 ]
机构：
[1] Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Dept Urol, D-97080 Wurzburg, Germany
来源：
EUROPEAN UROLOGY | 2009年 / 55卷 / 06期
关键词：
CANCER;
D O I：
10.1016/j.eururo.2009.02.024
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1490 / 1491
页数：2
相关论文
共 50 条
  • [31] KRAS and BRAF mutation and microsatellite status in gastric cancer in the elderly
    Arai, T.
    Wang, T.
    Matsuda, Y.
    Selci, A.
    Nonaka, K.
    Kakizalci, M.
    Aida, J.
    Takubo, K.
    Lshiwata, T.
    [J]. VIRCHOWS ARCHIV, 2016, 469 : S168 - S169
  • [32] KRAS and BRAF Mutation Detection with Multiplex Amplification and Pyrosequencing.
    Takei, H.
    Szanyi, M.
    Monzon, F.
    [J]. MODERN PATHOLOGY, 2011, 24 : 455A - 455A
  • [33] Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients
    Rako, I.
    Jakic-Razumovic, J.
    Katalinic, D.
    Sertic, J.
    Plestina, S.
    [J]. NEOPLASMA, 2012, 59 (04) : 376 - 383
  • [34] Lack of MAPK activation in papillary thyroid carcinoma with BRAF V600E mutation
    Zuo, Hui
    Nakamura, Yasushi
    Yasuoka, Hironao
    Nakamura, Misa
    Mori, Ichiro
    Miyauchi, Akira
    Kakudo, Kennichi
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [35] T1796A BRAF mutation is absent in Merkel cell carcinoma
    Worda, M
    Sreevidya, CS
    Ananthaswamy, HN
    Cerroni, L
    Kerl, H
    Wolf, P
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (01) : 229 - 232
  • [36] BRAF mutation in papillary thyroid carcinoma
    Cohen, J
    Xing, MZ
    Mambo, E
    Guo, ZM
    Wu, GG
    Trink, B
    Beller, U
    Westra, WH
    Ladenson, PW
    Sidransky, D
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (08) : 625 - 627
  • [37] BRAF mutation in papillary thyroid carcinoma
    Li, Xinying
    Abdel-Mageed, Asim B.
    Kandil, Emad
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2012, 5 (04): : 310 - 315
  • [38] Association between KRAS, NRAS, BRAF mutation status and clinicopathological prognostic factors in colorectal carcinoma in Turkish population
    Kocabey, D. Unal
    Cakir, E.
    Dilek, F. H.
    Kucukzeybek, B. Bolat
    Calli, A.
    [J]. VIRCHOWS ARCHIV, 2019, 475 : S237 - S237
  • [39] Renal cell carcinoma and oxidative stress: The lack of peroxisomes
    Frederiks, Wilma M.
    Bosch, Klazina S.
    Hoeben, Kees A.
    van Marle, Jan
    Langbein, Sigrun
    [J]. ACTA HISTOCHEMICA, 2010, 112 (04) : 364 - 371
  • [40] KRAS mutation profile in colorectal carcinoma and novel mutation -: Internal tandem duplication in KRAS
    Wojcik, Piotr
    Kulig, Jan
    Okon, Krzysztof
    Zazula, Monika
    Mozdzioch, Ilona
    Niepsuj, Anna
    Stachura, Jerzy
    [J]. POLISH JOURNAL OF PATHOLOGY, 2008, 59 (02) : 93 - 96
12345